Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV001171884 | SCV001334773 | uncertain significance | not provided | 2020-03-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002355133 | SCV002647762 | uncertain significance | Inborn genetic diseases | 2020-11-20 | criteria provided, single submitter | clinical testing | The p.M1948V variant (also known as c.5842A>G), located in coding exon 12 of the SETX gene, results from an A to G substitution at nucleotide position 5842. The methionine at codon 1948 is replaced by valine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. This alteration has been reported in a heterozygous state in two individuals with amyotrophic lateral sclerosis (ALS) (Kenna KP et al. J Med Genet, 2013 Nov;50:776-83; Andreini I et al. Amyotroph Lateral Scler Frontotemporal Degene, 2020 05;21:312-313). In addition, the in silico prediction for this alteration is inconclusive. Based on the supporting evidence, this variant is unlikely to be causative of SETX-related ALS; however, its contribution to the development of SETX-related ataxia is uncertain. |
Labcorp Genetics |
RCV002559645 | SCV003249986 | benign | Amyotrophic lateral sclerosis type 4; Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 | 2023-07-22 | criteria provided, single submitter | clinical testing |